.svg){kind=small}
Jul-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
MyHi is stocked at 76 licensed dispensaries across New York and New Jersey, 68 of them in New York, with the deepest coverage in New York, Rochester, Syracuse, Albany, and Auburn. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In July 2026, MyHi’s mix concentrated in Vapor Pens at 46.13% share with year-over-year decline of 72.11% and month-over-month decline of 6.50%, while Beverage held 29.55% share with year-over-year decline of 69.58% and month-over-month decline of 6.96%. Edible accounted for 24.32% share with a year-over-year decline of 52.95% but a month-over-month increase of 4.93%, alongside a brand-wide average price down 6.17% year over year to $32.09. With Beverage ranked 11 in New York and Vapor Pens still the largest revenue contributor, the pattern implies MyHi is relying on a shrinking Vapor Pens base while Edible is the only near-term stabilizer.
The sharper year-over-year contraction in Vapor Pens at 72.11% versus Edible at 52.95%, combined with Edible’s 4.93% month-over-month lift as Beverage fell 6.96% month over month, implies MyHi’s relative positioning is pivoting toward Edible formats where price points near $22.36 may be supporting trial. With Beverage at 29.55% share but ranked 11 in New York, and Vapor Pens down 6.50% month over month versus brand average price down 6.17% year over year, the mix suggests the brand can defend relevance by leaning into Edible momentum while treating Beverage and Vapor Pens as retention rather than growth engines.
Competitive Landscape
MyHi ranks #11 in NY Beverage in July 2026, falling 6 positions year over year from #5, and sliding 5 spots from #6 three months ago, while its historical peak was #4 in March 2025; meanwhile, Ayrloom held #1 with a 0-position YoY change despite a 5.36% YoY sales decline, and Harney Brothers Cannabis advanced from #7 to #3 on 327.37% YoY sales growth, indicating competitors are consolidating the top tier as MyHi cedes rank. Compared with Layup rising from #2 to #2 but posting 155.53% YoY sales growth, and Tune slipping from #3 to #5 with a 26.56% YoY sales decline, MyHi’s drop from #6 to #11 since April 2026 and its 7-rank gap to its March 2025 peak imply lost velocity relative to both accelerating climbers and retreating incumbents, signaling a need to reclaim distribution or innovation slots to re-enter the top 10.
Notable Products
THC/CBD 1:1 Relax Indica Grape Live Rosin Gummies 10-Pack (100mg THC, 100mg CBD) posted a 189.2% month-over-month surge to rank 1, while CBD/THC 2:1 Super Sativa Berry Gummies 10-Pack (100mg THC, 50mg CBD) fell 36.4% to rank 7. CBD/THC 1:3 Sour Diesel Live Rosin Disposable (1g) slipped 9.4% at rank 2 as Dreamy - CBD/THC 1:1 OG Kush Waterless Live Rosin Disposable (1g) declined 9.3% at rank 8, and three Beverage SKUs sat between rank 3 and rank 6 with mixed moves from +19.1% to -11.2%. The pattern implies a pivot toward balanced 1:1 edibles driving the leaderboard while Vapor Pens consolidate under pressure, tilting near-term assortment toward ingestibles over inhalables.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
